Cargando…

Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems

In the present study, two prospective Salmonella delivery strains, JOL2782 and JOL2837, were developed by gene deletions of lon and cpxR, which are related to cellular adhesion and intracellular survival. Additionally, sifA deletion was introduced for JOL2782, which confers immune susceptibility and...

Descripción completa

Detalles Bibliográficos
Autores principales: Aganja, Ram Prasad, Sivasankar, Chandran, Hewawaduge, Chamith, Lee, John Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526937/
https://www.ncbi.nlm.nih.gov/pubmed/36183131
http://dx.doi.org/10.1186/s13567-022-01096-z
_version_ 1784800980567588864
author Aganja, Ram Prasad
Sivasankar, Chandran
Hewawaduge, Chamith
Lee, John Hwa
author_facet Aganja, Ram Prasad
Sivasankar, Chandran
Hewawaduge, Chamith
Lee, John Hwa
author_sort Aganja, Ram Prasad
collection PubMed
description In the present study, two prospective Salmonella delivery strains, JOL2782 and JOL2837, were developed by gene deletions of lon and cpxR, which are related to cellular adhesion and intracellular survival. Additionally, sifA deletion was introduced for JOL2782, which confers immune susceptibility and improves antigen delivery. Similarly, the rfaL deletion and lpxE substitution for pagL were accomplished in JOL2837 to reduce virulence and endotoxicity. Thus, enhanced adhesion and invasion and reduced intracellular survival were attained. Furthermore, aspartic acid auxotrophic (asd) was deleted to impose Darwinian selection on retention of the foreign antigen-expressing plasmid. Both delivery strains induced sufficient cytokine expression, but the level was significantly lower than that of the wild-type strain; the lowest cytokine expression was induced by the JOL2837 strain, indicating reduced endotoxicity. In parallel, IgG production was significantly enhanced by both delivery strains. Thus, the innate and adaptive immunogenicity of the strains was ensured. The environmental safety of these strains was ascertained through faecal dissemination assays. The nonpathogenicity of these strains to the host was confirmed by body weight monitoring, survival assays, and morphological and histological assessments of the vital organs. The in vitro assay in murine and human cell lines and in vivo safety assessments in mice suggest that these novel strains possess safety, invasiveness, and immunogenicity, making them ideal delivery strains. Overall, the results clearly showed that strain JOL2782 with sifA deletion had higher invasiveness, demonstrating superior vaccine deliverability, while JOL2837 with lpxE substitution for pagL and rfaL deletion had outstanding safety potential with drastically abridged endotoxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13567-022-01096-z.
format Online
Article
Text
id pubmed-9526937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95269372022-10-03 Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems Aganja, Ram Prasad Sivasankar, Chandran Hewawaduge, Chamith Lee, John Hwa Vet Res Research Article In the present study, two prospective Salmonella delivery strains, JOL2782 and JOL2837, were developed by gene deletions of lon and cpxR, which are related to cellular adhesion and intracellular survival. Additionally, sifA deletion was introduced for JOL2782, which confers immune susceptibility and improves antigen delivery. Similarly, the rfaL deletion and lpxE substitution for pagL were accomplished in JOL2837 to reduce virulence and endotoxicity. Thus, enhanced adhesion and invasion and reduced intracellular survival were attained. Furthermore, aspartic acid auxotrophic (asd) was deleted to impose Darwinian selection on retention of the foreign antigen-expressing plasmid. Both delivery strains induced sufficient cytokine expression, but the level was significantly lower than that of the wild-type strain; the lowest cytokine expression was induced by the JOL2837 strain, indicating reduced endotoxicity. In parallel, IgG production was significantly enhanced by both delivery strains. Thus, the innate and adaptive immunogenicity of the strains was ensured. The environmental safety of these strains was ascertained through faecal dissemination assays. The nonpathogenicity of these strains to the host was confirmed by body weight monitoring, survival assays, and morphological and histological assessments of the vital organs. The in vitro assay in murine and human cell lines and in vivo safety assessments in mice suggest that these novel strains possess safety, invasiveness, and immunogenicity, making them ideal delivery strains. Overall, the results clearly showed that strain JOL2782 with sifA deletion had higher invasiveness, demonstrating superior vaccine deliverability, while JOL2837 with lpxE substitution for pagL and rfaL deletion had outstanding safety potential with drastically abridged endotoxicity. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13567-022-01096-z. BioMed Central 2022-10-01 2022 /pmc/articles/PMC9526937/ /pubmed/36183131 http://dx.doi.org/10.1186/s13567-022-01096-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Aganja, Ram Prasad
Sivasankar, Chandran
Hewawaduge, Chamith
Lee, John Hwa
Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title_full Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title_fullStr Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title_full_unstemmed Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title_short Safety assessment of compliant, highly invasive, lipid A-altered, O-antigen-defected Salmonella strains as prospective vaccine delivery systems
title_sort safety assessment of compliant, highly invasive, lipid a-altered, o-antigen-defected salmonella strains as prospective vaccine delivery systems
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526937/
https://www.ncbi.nlm.nih.gov/pubmed/36183131
http://dx.doi.org/10.1186/s13567-022-01096-z
work_keys_str_mv AT aganjaramprasad safetyassessmentofcomplianthighlyinvasivelipidaalteredoantigendefectedsalmonellastrainsasprospectivevaccinedeliverysystems
AT sivasankarchandran safetyassessmentofcomplianthighlyinvasivelipidaalteredoantigendefectedsalmonellastrainsasprospectivevaccinedeliverysystems
AT hewawadugechamith safetyassessmentofcomplianthighlyinvasivelipidaalteredoantigendefectedsalmonellastrainsasprospectivevaccinedeliverysystems
AT leejohnhwa safetyassessmentofcomplianthighlyinvasivelipidaalteredoantigendefectedsalmonellastrainsasprospectivevaccinedeliverysystems